⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29960765 | 0.72 | TAAR1 (0.41) | — | |
| Hydrochloric Acid SCHEMBL29960613 | 0.71 | TAAR1 (0.41) | — | |
| SCHEMBL8074808 | 0.70 | — | — | |
| SCHEMBL20017867 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL29960779 | 0.68 | TAAR1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL29959968 | 0.68 | TAAR1 (0.44) | — | |
| SCHEMBL29960294 | 0.67 | — | — | |
| SCHEMBL29960433 | 0.64 | TAAR1 (0.41) | — | |
| SCHEMBL8075447 | 0.64 | MAP3K14 (0.43) | — | |
| Hydrochloric Acid SCHEMBL29960379 | 0.63 | TAAR1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180071259-A1 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | ALLERGAN, INC. | 2018-03-15 | — | — | US | disclosed |
| US-20170079956-A1 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | ALLERGAN, INC. | 2017-03-23 | — | — | US | disclosed |
| US-9545394-B2 | Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists | ALLERGAN, INC. (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160158199-A1 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | ALLERGAN, INC. | 2016-06-09 | — | — | US | disclosed |
| US-9289420-B2 | Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists | ALLERGAN, INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-20140066483-A1 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | ALLERGAN, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8575207-B2 | Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists | ALLERGAN, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120041031-A1 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | ALLERGAN, INC (US) | 2012-02-16 | — | — | US | disclosed |